Genomic Engenharia Molecular

What Genomic Engenharia Molecular does

Genomic Engenharia Molecular is a Brazilian specialty genetics laboratory founded in 1991 in São Paulo by Prof. Dr. Martin Ritter Whittle, Prof. Dr. Fernando de Castro Reinach, and two business administrators. The company pioneered the introduction of STR-based PCR human identification technology to Brazil alongside Fiocruz, Hospital Albert Einstein, and Embrabio, and has performed over 100,000 DNA examinations since inception. Its service portfolio spans paternity and relationship testing (Trio, Duo, joint paternity/maternity, sibling, deceased-parent reconstruction), forensic DNA analysis from degraded biological samples, non-invasive prenatal paternity testing from the 11th week of gestation, hereditary disease predisposition panels (BRCA1/2 expanded 21-gene, CFTR, FMR1, SMN1/SMN2, MTHFR, APOE, PKD1, CYP21A2), pharmacogenetic panels (CYP2C9/VKORC1, UGT1A1, CYP2D6, NAT-2, SLCOB1, psychotropic panel), nutrigenetics, and research services including Sanger DNA sequencing and molecular cloning.

The underlying technology is built on proprietary PCR multiplexes amplifying up to 21 autosomal STR loci (exceeding the commercial 15-locus standard), real-time PCR quantification systems with inhibitor detection, capillary electrophoresis on Applied Biosystems 3130xl/3500 sequencers, and proprietary consumables including GemRox-511 and GemDyc-512 molecular weight standards and the GEMPLEX CGG FMR1 assay. Genomic holds CAP (College of American Pathologists) and CREMESP certifications.

The company generates revenue primarily through one-time fees per test across consumer (direct-to-consumer e-commerce via the DNA em Casa storefront, with home kits priced R$389–R$1,250), healthcare-provider, and government channels. Distribution occurs through approximately 1,100 accredited partner laboratories across all Brazilian states feeding samples to the São Paulo flagship laboratory, direct e-commerce, public tender contracts (licitações) for forensic testing across multiple states, and in-person scheduling at the Tatuapé headquarters. Proprietary reagent kits (GemRox, GemDyc, GEMPLEX) are also sold to other laboratories.

Name

Genomic Engenharia Molecular

Legal name

Genomic Engenharia Molecular

Website

https://genomic.com.br

Company type

Private

Founded year

1991

Operating status

Operating

Short description

Genomic Engenharia Molecular is a São Paulo–based specialty genetics laboratory founded in 1991, offering DNA paternity, forensic, prenatal, pharmacogenetic, and hereditary disease testing to Brazilian consumers, courts, physicians, and researchers via a 1,100-partner-laboratory network.

Ownership category

akta.pro rank

Product category

Genetic Testing Services

NAICS

Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro industry

PRIMARYHLAFAMAE

Molecular Diagnostics & Genomics Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAFAMAH

Genetic & Prenatal Testing Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAAALAD

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

SECONDARYHLAGANAA

Genomics & Next-Generation Sequencing (NGS) Services

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

SECONDARYHLAAAMAJ

Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics)

Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

• DNA paternity testing
• Forensic DNA analysis
• Genetic disease testing
• Pharmacogenetics testing
• DNA sequencing services

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. DNA Paternity and Genetic Relationship Testing: One-time fee per test covering sample collection kit, laboratory analysis, and result delivery. Pricing varies by test type (Trio/Duo), collection speed (standard/48h/23h), and sample type (blood/saliva/nails). Primary revenue driver. Over 100,000 tests performed since founding.
2. Home Collection Kit Sales (DNA em Casa): Direct-to-consumer e-commerce sales of DNA collection kits. Customers purchase online and self-collect at home. Kit prices range from R$389 to R$1,250 depending on test complexity and turnaround time.
3. Pharmacogenetics Testing: Clinical genetic tests for drug sensitivity including UGT1A1 (Irinotecan), CYP2C9/VKORC1 (Warfarin), NAT-2 (Isoniazida), CYP2D6 (Codeine), SLCO1B1 (Statins), and a comprehensive Psychopharmacogenetics Panel. Billed per test.
4. Genetic Disease Risk Tests: Single-gene and multi-gene panel tests for hereditary disease predisposition: BRCA1/BRCA2 (breast/ovarian cancer), CFTR (cystic fibrosis), FMR1 (Fragile X), SMN1/SMN2 (SMA), MTHFR, APOE (Alzheimer), ACE, F2/F5 (thrombosis), PKD1, CYP21A2 (CAH). Billed per test.
5. Forensic DNA Analysis: Specialized forensic testing on degraded, decomposed, or non-standard biological samples (bones, teeth, hair, nails, semen, vaginal swabs, tissues, autopsy materials) for judicial identification and paternity cases. Includes exhumation services with perito accompaniment.
6. DNA Sequencing Services: Sanger DNA sequencing service for research clients. Pricing at R$35 per reaction. Reactions performed on Applied Biosystems 3130xl or 3500 sequencers. Additional fees for purification (R$14) and quantification (R$6.50 if quantity insufficient).
7. Public Tenders (Perícias Públicas): Competitive government procurement contracts for DNA testing services across Brazilian states, serving the judicial system and public human rights programs. Won the tender for the DNA Bank of Families of Disappeared Political Victims in 2006.
8. Specialized Reagent Kits (GemRox, GemDyc, GEMPLEX): Sale of proprietary internal molecular weight standards (GemRox-511, GemDyc-512) and specialty assay kits (GEMPLEX CGG) to other laboratories and research institutions.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

Genomic Engenharia Molecular is a specialized molecular genetics laboratory that performs DNA-based diagnostic and forensic testing, including paternity/maternity tests, forensic identification from degraded biological samples, genetic disease risk panels (BRCA1/2, CFTR, FMR1, SMN1/SMN2, MTHFR, APOE), pharmacogenetics tests (CYP2C9, VKORC1, CYP2D6, SLCO1B1), nutrigenetics, non-invasive prenatal paternity testing, and DNA sequencing/cloning services for research clients. It sells proprietary molecular biology reagents (GemRox-511, GemDyc-512, GEMPLEX CGG) and operates a direct-to-consumer home collection kit (DNA em Casa) plus a network of approximately 1,100 accredited partner laboratories across Brazil.

Product overview

Genomic Engenharia Molecular is a specialized genetics laboratory founded in 1991, offering a comprehensive portfolio of DNA-based diagnostic and forensic services. The core offerings include paternity/maternity testing (Trio, Duo, and Joint Paternity/Maternity formats), forensic DNA analysis from various biological materials, and genetic predisposition testing for diseases including cancer (breast/ovarian via BRCA1/BRCA2), cardiovascular conditions, neurological disorders (Alzheimer's), and pharmacogenetic panels. The company has developed proprietary R&D products including GEMPLEX CGG for Fragile X analysis, molecular weight standards (GEMROX-511, GEMDYC-512), and a human DNA quantification system. Key services include non-invasive prenatal paternity testing, DNA sequencing, mitochondrial DNA analysis, and genetic identity profiling. The laboratory operates with approximately 1,100 affiliated partner laboratories across Brazil and has performed over 100,000 examinations since founding.

Differentiator

Problem solved

Functional benefit

Brands

• GenomiCalc: Website for statistical calculations including Hardy-Weinberg equilibrium, paternity probability calculations, and Bayesian network calculations for complex cases

Products and services

• Paternidade Trio (Trio Paternity DNA Test) DNA paternity test involving the alleged father, mother, and child using PCR with analysis of 17-29 STR loci plus amelogenin sex marker for internal quality control. Used by Brazilian individuals, courts, and immigration cases.
• Paternidade Duo (Duo Paternity DNA Test) DNA paternity test involving the alleged father and child (or mother and child) without the third parent. Results delivered in 5 business days.
• Exame de Irmandade (Sibling DNA Test) Sibling DNA test to evaluate whether two individuals are biological full or half siblings, calculating full sibling and half-sibling indices based on genetic analysis.
• Análises Forenses (Forensic DNA Analysis) Forensic DNA analysis services including testing from bones, teeth, nail fragments, hair, saliva, seminal fluid, umbilical cord, vaginal swabs, anatomopathological material, and decomposed tissues. Court-admissible with chain-of-custody.
• Kit de Coleta Domiciliar / DNA em Casa (Home DNA Collection Kit) Direct-to-consumer DNA collection kit sold online for paternity/relationship testing. Available in Trio, Duo, and additional formats; sample types include saliva, blood, or nails; turnarounds from 10 business days to 23 hours. Excludes judicial cases.
• Testes Genéticos (Hereditary Disease Genetic Tests) Hereditary disease genetic tests including ACE (cardiac), APOE (Alzheimer's), BRCA1/BRCA2 (breast/ovarian cancer), CFTR (cystic fibrosis), CYP21A2 (CAH), FMR1 (Fragile X), F2/F5 (thrombosis), PKD1 (polycystic kidney), MTHFR, and SMN1/SMN2 (SMA).
• Farmacogenética (Pharmacogenetics) Pharmacogenetic testing for drug sensitivity including UGT1A1 (irinotecan toxicity), CYP2C9/VKORC1 (warfarin sensitivity), NAT-2 (isoniazid sensitivity), CYP2D6 (codeine sensitivity), psychotropic drug panel, and SLCO1B1 (statin sensitivity).
• Nutrigenética (Nutrigenetics)

Quantifiable outcome

• Non-invasive prenatal paternity testing achieves ≥99.9% confirmation probability and 100% exclusion rate
• +4 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Fiocruz, Hospital Albert Einstein, EmbrabiocoreStrategic or Co-development PartnerGenomic was a pioneer in Brazil, alongside Fiocruz, Hospital Albert Einstein, and Embrabio, in the application of nucleic acid amplification techniques (particularly PCR) for human genetics. This pioneering partnership established the foundation for molecular genetics in Brazil.
• IME-USP (Institute of Mathematics and Statistics, University of São Paulo)coreStrategic or Co-development PartnerPartnership with mathematicians and statisticians from IME-USP and consultants from Supremum, with FAPESP support, to develop GenomiCalc (genomicalc.com.br) – a web platform providing Hardy-Weinberg equilibrium calculations based on Brazilian population allele frequencies, paternity probability calculations (trios and duos), and Bayesian network calculations for complex cases with missing individuals.
• GHEP-ISFG (Grupo Hispano-Luso-Americano de Hemogenética Forense / International Society of Forensic Genetics)coreOthersActive participation in GHEP-ISFG collaborative exercises, proficiency testing programs, and congresses. Genomic contributes to and participates in inter-laboratory comparison studies on autosomal STRs, Y-STRs, X-STRs, and mtDNA, including the GHEP-MIX series of mixture profile exercises.
• XXVI Brazilian Medical Genetics Congress (CBGM 2014)minorOthersPresented poster on 'Determination of SMN1 and SMN2 gene copy numbers by quantitative PCR' at the XXVI Brazilian Medical Genetics Congress in Fortaleza.

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

Broad incumbents

• MyHeritage DNA: International DTC genetic testing platform with ancestry and relationship testing. Operates in Brazil and competes for the same consumer-direct testing customer as Genomic's DNA em Casa storefront.
• SOPHiA Genetics: Global clinical genomics platform using AI-driven analysis of NGS data for rare disease and oncology. Comparable in the clinical genomics layer but a broader enterprise-platform play versus Genomic's PCR-based specialty lab.
• 23andMe: Global leader in direct-to-consumer genetic testing. Comparable as DTC genomics player, though Genomic focuses on relationship/forensics testing rather than ancestry and health-risk reporting.

Others

• Thermo Fisher Scientific: Global supplier of Sanger and NGS instruments, reagents, and genetic testing solutions. Compares as the upstream technology provider Genomic depends on (e.g., Applied Biosystems 3130xl/3500 sequencers) and implicitly competitive in clinical testing reagents.

Regional players

• AlphaBiolabs: UK-based DNA testing laboratory offering paternity, relationship, and drug & alcohol testing. Comparable in DTC DNA testing business model but operating in a different geography.

Direct peers

• FamilyTreeDNA: US-based DNA testing company specializing in relationship (paternity, sibling) and ancestry testing. Directly comparable in paternity/relationship testing value proposition and consumer channels.
• Genera Biotech: Brazilian clinical genomics provider focused on hereditary cancer, pharmacogenetics, and nutrigenetics. Directly overlaps Genetic's clinical genetic testing menu and physician-customer segment.
• DNA Diagnostics Center (DDC): US-based specialty DNA testing lab focused on paternity, relationship, and immigration testing. Comparable in forensic-adjacent paternity testing service model and quality standards.
• Mendelics Análise Genômica: Brazilian clinical genomics laboratory offering hereditary disease panels, pharmacogenetics, and NIPT services. Directly comparable as a Brazilian specialty clinical genetics lab competing for the same healthcare-provider customers.
• EasyDNA: International DNA paternity and relationship testing service with Brazil presence. Directly competes with Genomic's home collection kit and relationship testing business.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCqJ-kz0aDaTJvZ8gO6ABQKA
• Facebookfacebook.com/labgenomic
• Xx.com/labgenomic

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genomic Engenharia Molecular